{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "La Vergne",
      "state": "TN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "91751",
      "recalling_firm": "The Harvard Drug Group",
      "address_1": "341 Mason Rd",
      "address_2": "N/A",
      "postal_code": "37086-3606",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "N/A",
      "distribution_pattern": "Distributed Nationwide in the USA",
      "recall_number": "D-0432-2023",
      "product_description": "Carbidopa and Levodopa Tablets, USP 25 mg/100 mg, 10x10 Unit Dose carton, Rx Only, Manufactured in Czech Republic by: Teva Czech Industries, s.r.o. Opava-Komarov, Czech Republic, Manufactured for: Teva Pharmaceuticals USA, Inc. Parsippany, NJ 07054, Packaged and Distributed by: Major Pharmaceuticals Indianapolis, IN 46268 USA. NDC 0904-7257-61, UPC 3 09047 25761 4",
      "product_quantity": "17,586 cartons",
      "reason_for_recall": "Packaging defect: observed packaging defect, blister packaging inadequately sealed.",
      "recall_initiation_date": "20230223",
      "center_classification_date": "20230302",
      "termination_date": "20240430",
      "report_date": "20230308",
      "code_info": "Lot: M04145 Exp. 01/2024",
      "more_code_info": ""
    }
  ]
}